by Truveta staff | Dec 15, 2023 | Research
As 2023 draws to a close and we reflect on a busy and exciting year for Truveta, something that stands out is the breadth and depth of research Truveta Research has been able to produce using Truveta Data and Truveta Studio. From studying new Alzheimer’s disease...
by Truveta Research | Nov 2, 2023 | Research, Research Insights
Adalimumab (Humira) and etanercept (Enbrel) are high-cost specialty medications used to treat a variety of autoimmune diseases. Medication adherence is often influenced by social drivers of health, so we aimed to measure adherence using the proportion of days covered...
by Truveta Research | Oct 17, 2023 | Research, Research Insights
Social drivers of health (SDOH), such as increased financial struggles and decreased social support, have been shown to be correlated with decreased medication adherence. In this study of patients with type 2 diabetes, we saw an increased rate of medication adherence...
by Truveta Research | Oct 5, 2023 | Research, Research Insights
Annually, over 125,000 deaths are associated with poor medication adherence. The proportion of days covered (PDC) is a common method to measure adherence. When controlling for age, sex, race, and ethnicity, we found similar rates of first year medication adherence for...
by Truveta staff | Aug 9, 2023 | Data, News
Today Truveta announced the addition of new in-depth medication dispense data to help researchers study safety and effectiveness, medication adherence, and adverse events. Medication dispense data helps researchers understand patients’ actual use of medications. With...
